ruthenium has been researched along with triazoles in 52 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (25.00) | 29.6817 |
| 2010's | 28 (53.85) | 24.3611 |
| 2020's | 11 (21.15) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, TL; Day, MW; Ding, S; Grubbs, RH; Morgan, JP; Sanford, MS; Scholl, M; Trnka, TM; Wilhelm, TE | 1 |
| Arion, VB; Fremuth, M; Jakupec, MA; Keppler, BK; Kukushkin, VY; Pombeiro, AJ; Reisner, E | 1 |
| Barrera, MA; Magán, R; Marín, C; Rosales, MJ; Salas, JM; Sánchez-Moreno, M | 1 |
| Arion, VB; Eichinger, A; Guedes da Silva, MF; Keppler, BK; Kukushkin, VY; Lichtenecker, R; Pombeiro, AJ; Reisner, E | 1 |
| Arion, VB; Eichinger, R; Groessl, M; Hartinger, CG; Jakupec, MA; Keppler, BK; Reisner, E; Semenova, O; Timerbaev, AR | 1 |
| Cafici, L; Canonico, PL; Galli, U; Genazzani, AA; Imperio, D; Pagliai, F; Pirali, T; Sorba, G; Tron, GC | 1 |
| Fitchett, CM; Keene, FR; Richardson, C; Steel, PJ | 1 |
| Boren, BC; Fokin, VV; Jia, G; Lin, Z; Narayan, S; Rasmussen, LK; Zhang, L; Zhao, H | 1 |
| Friebe, C; Görls, H; Hager, MD; Hoogenboom, R; Schubert, US; Schulze, B; Winter, A | 1 |
| Kniess, T; Pietzsch, J; Suresh, M; Tang, X; Wuest, F | 1 |
| Ackermann, L; Born, R; Vicente, R | 1 |
| Kelly, AR; Kesavan, S; Marcaurelle, LA; Marié, JC; Wei, J; Windmon, N; Young, DW | 1 |
| Crich, D; Yang, F | 1 |
| Abell, AD; Bräuner-Osborne, H; Kvist, T; Mathiesen, JM; Nielsen, B; Pedersen, DS; Stanley, NJ; Taylor, DK | 1 |
| Desai, AA | 1 |
| Alessio, E; Bratsos, I; Genova-Kalou, P; Košmrlj, J; Turel, I; Urankar, D; Zangrando, E | 1 |
| Baxter, CA; Brands, KM; Cleator, E; Krska, SW; Reamer, RA; Strotman, NA; Wallace, DJ; Wright, TJ | 1 |
| Avrutina, O; Biesalski, M; Buntkowsky, G; Empting, M; Fabritz, S; Kolmar, H; Meusinger, R; Reinwarth, M; Voigt, S | 1 |
| Ringenberg, MR; Ward, TR | 1 |
| Charman, SA; Gregg, D; Morizzi, J; Poulsen, SA; Salmon, AJ; Supuran, CT; Vullo, D; Williams, ML; Wu, QK | 1 |
| Elliott, PI; Gibson, EA; Grkinic, S; Rice, CR; Uppal, BS; Welby, CE; Zahid, A | 1 |
| Jia, G; Liu, PN; Siyang, HX; Tse, SK; Zhang, L | 1 |
| Castonguay, A; Doucet, C; Juhas, M; Maysinger, D | 1 |
| Brennan, C; Browne, WR; Draksharapu, A; McGarvey, JJ; Pryce, MT; Vos, JG | 1 |
| Fukuzawa, S; Inomata, S; Ogata, K | 1 |
| Kemmink, J; Liskamp, RM; Rijkers, DT; Zhang, J | 1 |
| Arion, VB; Hartinger, CG; Jakupec, MA; Kandioller, W; Keppler, BK; Meier, SM; Metzler-Nolte, N; Novak, M | 1 |
| Astruc, D; Ruiz, J; Salmon, L; Wang, D | 1 |
| Albrecht, M; Bell, AP; Boland, JJ; Byrne, JP; Gunnlaugsson, T; Kitchen, JA; Kotova, O; Leigh, V | 1 |
| Crot, S; Dyson, PJ; Kilpin, KJ; Kitchen, JA; Riedel, T | 1 |
| Alloatti, D; Armaroli, S; Barbarino, M; Cabri, W; Carollo, V; Castorina, M; Cervoni, ML; Corsi, M; Ferrini, S; Foderà, R; Giannini, G; Giannotti, L; Guglielmi, MB; Manetti, F; Milazzo, FM; Pisano, C; Taddei, M; Vesci, L | 1 |
| Chakraborty, S; Chowdhury, B; Dutta, R; Ghosh, P; Khatua, S | 1 |
| Fokin, VV; Oakdale, JS; Sit, RK | 1 |
| Karthik, S; Ramachary, DB; Shashank, AB | 1 |
| Aprile, S; Del Grosso, E; Grosa, G; Massarotti, A; Mercalli, V; Sorba, G; Tron, GC | 1 |
| Li, H; Liu, Z; Lu, A; Sun, S; Wang, C; Xu, Y; Yang, K; Zhang, Y | 1 |
| Chandanshive, JZ; Comes Franchini, M; Ferrini, S; Giannini, G; Lena, S; Taddei, M; Tafi, A | 1 |
| Chen, M; Li, L; Mei, J; Nie, H; Qin, A; Shi, Y; Sun, JZ; Tang, BZ; Wang, J | 1 |
| Carneiro, ZA; Carvalho, I; Carvalho, MR; de Andrade, P; de Melo, EB; Galo, OA; Lopes, CD; Sesti-Costa, R; Silva, JS | 1 |
| Hejl, M; Jakupec, MA; Kandioller, W; Keppler, BK; Klose, MHM; Riedl, CA; Roller, A | 1 |
| Clark, RJ; Liu, P; Zhu, L | 1 |
| Dobrzańska, L; Fandzloch, M; Jędrzejewski, T; Jezierska, J; Wiśniewska, J; Łakomska, I | 1 |
| Fandzloch, M; Gubernator, J; Jaromin, A; Lewińska, A; Sitkowski, J; Wiśniewska, J; Wojtczak, A; Zaremba-Czogalla, M; Łakomska, I | 1 |
| Craik, DJ; de Veer, SJ; Durek, T; Harvey, PJ; King, GJ; Law, RHP; Swedberg, JE; Wang, CK; White, AM; Wu, G; Yap, K | 1 |
| Bretner, M; Buchowicz, W; Kamiński, R; Koszytkowska-Stawińska, M; Mazur, M; Mrozowicz, M; Ochal, Z; Wińska, P | 1 |
| Anandan, S; Marraiki, N; Ramachandran, M; Syed, A | 1 |
| Cabral, R; Carvalho, B; Fernandes, AR; Fernández, JAA; Friães, S; Gomes, CSB; Lenis-Rojas, OA; Roma-Rodrigues, C; Royo, B; Sanchez, L; Vila, SF | 1 |
| Chu, WK; Makhubela, BCE; Rono, CK | 1 |
| Brożyna, AA; Dobrzańska, L; Fandzloch, M; Jędrzejewski, T; Sitkowski, J; Wiśniewska, J; Wrotek, S | 1 |
| Gama, N; Makhubela, B; Meyer, D; Putterill, B; Rono, C | 1 |
| Alary, F; Boota, RZ; Chu, D; Dixon, IM; Eastham, K; Elliott, PIP; Hardman, SJO; Rice, CR; Scattergood, PA; Soupart, A | 1 |
| Arthur, M; Bagdad, Y; Barnier, JP; Bouchet, F; Ethève-Quelquejeu, M; Iannazzo, L; Miteva, MA; Sayah, I | 1 |
52 other study(ies) available for ruthenium and triazoles
| Article | Year |
|---|---|
Synthesis and activity of ruthenium alkylidene complexes coordinated with phosphine and N-heterocyclic carbene ligands.
Topics: Alkenes; Crystallography, X-Ray; Heterocyclic Compounds; Hydrocarbons; Imidazoles; Ligands; Methane; Molecular Structure; Organometallic Compounds; Phosphines; Ruthenium; Triazoles | 2003 |
Synthesis, X-ray diffraction structures, spectroscopic properties, and in vitro antitumor activity of isomeric (1H-1,2,4-triazole)Ru(III) complexes.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Chemical Phenomena; Chemistry, Physical; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Indicators and Reagents; Organometallic Compounds; Ruthenium; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Tetrazolium Salts; Thiazoles; Triazoles | 2003 |
Activities of Pt(II) and Ru(III) triazole-pyrimidine complexes against Trypanosoma cruzi and T. brucei brucei.
Topics: Animals; Biotransformation; DNA, Protozoan; Magnetic Resonance Spectroscopy; Organometallic Compounds; Organoplatinum Compounds; Protozoan Proteins; Pyrimidines; RNA, Protozoan; Ruthenium; Triazoles; Trypanosoma brucei brucei; Trypanosoma cruzi; Uridine | 2004 |
Tuning of redox potentials for the design of ruthenium anticancer drugs -- an electrochemical study of [trans-RuCl(4)L(DMSO)](-) and [trans-RuCl(4)L(2)](-) complexes, where L = imidazole, 1,2,4-triazole, indazole.
Topics: Antineoplastic Agents; Dimethyl Sulfoxide; Drug Design; Electrochemistry; Imidazoles; Indazoles; Molecular Conformation; Molecular Structure; Organometallic Compounds; Oxidation-Reduction; Ruthenium; Stereoisomerism; Triazoles | 2004 |
Structure-activity relationships for NAMI-A-type complexes (HL)[trans-RuCl4L(S-dmso)ruthenate(III)] (L = imidazole, indazole, 1,2,4-triazole, 4-amino-1,2,4-triazole, and 1-methyl-1,2,4-triazole): aquation, redox properties, protein binding, and antiprolif
Topics: Albumins; Antineoplastic Agents; Cell Line, Tumor; Colorimetry; Crystallography, X-Ray; Dimethyl Sulfoxide; Drug Screening Assays, Antitumor; Drug Stability; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Imidazoles; Organometallic Compounds; Oxidation-Reduction; Potentiometry; Protein Binding; Ruthenium; Ruthenium Compounds; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Transferrin; Triazoles; Water | 2007 |
Replacement of the lactone moiety on podophyllotoxin and steganacin analogues with a 1,5-disubstituted 1,2,3-triazole via ruthenium-catalyzed click chemistry.
Topics: 4-Butyrolactone; Antineoplastic Agents; Catalysis; Cell Line, Tumor; Humans; Lactones; Lignans; Molecular Conformation; Podophyllotoxin; Ruthenium; Triazoles; Tubulin | 2007 |
4,5-di(2-pyridyl)-1,2,3-triazolate: the elusive member of a family of bridging ligands that facilitate strong metal-metal interactions.
Topics: 2,2'-Dipyridyl; Chelating Agents; Crystallography, X-Ray; Electrochemistry; Ligands; Molecular Structure; Organometallic Compounds; Ruthenium; Spectrophotometry, Ultraviolet; Triazoles | 2008 |
Ruthenium-catalyzed azide-alkyne cycloaddition: scope and mechanism.
Topics: Alkynes; Azides; Catalysis; Cyclization; Organometallic Compounds; Ruthenium; Triazoles | 2008 |
2,2':6',2''-Terpyridine meets 2,6-bis(1H-1,2,3-triazol-4-yl)pyridine: tuning the electro-optical properties of ruthenium(II) complexes.
Topics: Crystallography, X-Ray; Electrochemistry; Models, Molecular; Molecular Structure; Organometallic Compounds; Photochemistry; Pyridines; Ruthenium; Triazoles | 2009 |
Synthesis and cyclooxygenase inhibition of various (aryl-1,2,3-triazole-1-yl)-methanesulfonylphenyl derivatives.
Topics: Catalysis; Copper; Cyclooxygenase Inhibitors; Inhibitory Concentration 50; Ruthenium; Structure-Activity Relationship; Triazoles | 2009 |
Ruthenium-catalyzed direct arylations of N-aryl 1,2,3-triazoles with aryl chlorides as electrophiles.
Topics: Catalysis; Chlorides; Green Chemistry Technology; Hydrocarbons, Aromatic; Ruthenium; Solvents; Triazoles | 2009 |
Accessing skeletal diversity using catalyst control: formation of n and n + 1 macrocyclic triazole rings.
Topics: Alkynes; Catalysis; Combinatorial Chemistry Techniques; Cyclization; Molecular Structure; Ruthenium; Triazoles | 2009 |
Phenylthiomethyl glycosides: convenient synthons for the formation of azidomethyl and glycosylmethyl glycosides and their derivatives.
Topics: Catalysis; Copper; Glycoconjugates; Glycosides; Ruthenium; Triazoles | 2009 |
1,2,3-triazolyl amino acids as AMPA receptor ligands.
Topics: Amino Acids; Binding Sites; Catalysis; Computer Simulation; Copper; Ligands; Receptors, AMPA; Ruthenium; Triazoles | 2010 |
Sitagliptin manufacture: a compelling tale of green chemistry, process intensification, and industrial asymmetric catalysis.
Topics: Biocatalysis; Diabetes Mellitus, Type 2; Green Chemistry Technology; Humans; Pyrazines; Ruthenium; Sitagliptin Phosphate; Transaminases; Triazoles | 2011 |
1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for the preparation of ruthenium complexes with potential anticancer activity.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chelating Agents; Crystallography, X-Ray; Humans; Ligands; Magnetic Resonance Spectroscopy; Organometallic Compounds; Ruthenium; Triazoles | 2011 |
Reaction development and mechanistic study of a ruthenium catalyzed intramolecular asymmetric reductive amination en route to the dual Orexin inhibitor Suvorexant (MK-4305).
Topics: Amination; Azepines; Catalysis; Hydrogenation; Intracellular Signaling Peptides and Proteins; Kinetics; Neuropeptides; Orexins; Ruthenium; Stereoisomerism; Triazoles | 2011 |
"Triazole bridge": disulfide-bond replacement by ruthenium-catalyzed formation of 1,5-disubstituted 1,2,3-triazoles.
Topics: Amino Acid Sequence; Catalysis; Click Chemistry; Disulfides; Peptides; Peptidomimetics; Ruthenium; Triazoles; Trypsin; Trypsin Inhibitors | 2011 |
Merging the best of two worlds: artificial metalloenzymes for enantioselective catalysis.
Topics: Catalysis; Coordination Complexes; DNA; Enzymes; Metalloproteins; Models, Molecular; Oxidation-Reduction; Pyrazines; Ruthenium; Sitagliptin Phosphate; Stereoisomerism; Triazoles | 2011 |
Metallocene-based inhibitors of cancer-associated carbonic anhydrase enzymes IX and XII.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Caco-2 Cells; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrases; Coordination Complexes; Cyclopentanes; Ferrous Compounds; Humans; Metallocenes; Microsomes, Liver; Permeability; Ruthenium; Solubility; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2012 |
Synthesis, characterisation and theoretical study of ruthenium 4,4'-bi-1,2,3-triazolyl complexes: fundamental switching of the nature of S1 and T1 states from MLCT to MC.
Topics: Acetonitriles; Models, Theoretical; Molecular Structure; Organometallic Compounds; Quantum Theory; Ruthenium; Triazoles | 2012 |
RuH2(CO)(PPh3)3 catalyzed selective formation of 1,4-disubstituted triazoles from cycloaddition of alkynes and organic azides.
Topics: Alkynes; Azides; Catalysis; Cyclization; Molecular Structure; Organometallic Compounds; Ruthenium; Triazoles | 2012 |
New ruthenium(II)-letrozole complexes as anticancer therapeutics.
Topics: Adenine; Adenocarcinoma; Antineoplastic Agents; Aromatase Inhibitors; Autophagy; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Coordination Complexes; Crystallography, X-Ray; Curcumin; Drug Interactions; Drug Screening Assays, Antitumor; Female; Glioblastoma; Humans; Letrozole; Nitriles; Ruthenium; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2012 |
Unexpected reversible pyrazine based methylation in a Ru(II) complex bearing a pyrazin-2'-yl-1,2,4-triazolato ligand and its effect on acid/base and photophysical properties.
Topics: Acid-Base Equilibrium; Ligands; Methylation; Molecular Structure; Organometallic Compounds; Photochemical Processes; Pyrazines; Ruthenium; Stereoisomerism; Triazoles | 2013 |
Position-selective intramolecular aromatic C-H bond activation of 1,2,3-triazol-5-ylidene (tzNHC) ligands in (p-cymene)ruthenium(II) complexes.
Topics: Cymenes; Ligands; Models, Molecular; Molecular Structure; Monoterpenes; Organometallic Compounds; Ruthenium; Triazoles | 2013 |
Synthesis of 1,5-triazole bridged vancomycin CDE-ring bicyclic mimics using RuAAC macrocyclization.
Topics: Alkynes; Azides; Bridged Bicyclo Compounds; Cyclization; Models, Molecular; Molecular Structure; Organometallic Compounds; Ruthenium; Triazoles; Vancomycin | 2013 |
Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate.
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Ligands; Monoterpenes; Oligopeptides; Pyrones; Ruthenium; Spectrometry, Mass, Electrospray Ionization; Stereoisomerism; Structure-Activity Relationship; Triazoles | 2013 |
A recyclable ruthenium(II) complex supported on magnetic nanoparticles: a regioselective catalyst for alkyne-azide cycloaddition.
Topics: Alkynes; Azides; Catalysis; Cyclization; Magnetite Nanoparticles; Molecular Structure; Organometallic Compounds; Particle Size; Ruthenium; Stereoisomerism; Surface Properties; Triazoles | 2013 |
Synthesis, structural, photophysical and electrochemical studies of various d-metal complexes of btp [2,6-bis(1,2,3-triazol-4-yl)pyridine] ligands that give rise to the formation of metallo-supramolecular gels.
Topics: Coordination Complexes; Crystallography, X-Ray; Gels; Hydrogen Bonding; Iridium; Ligands; Luminescence; Models, Molecular; Nickel; Oxidation-Reduction; Platinum; Pyridines; Ruthenium; Triazoles | 2014 |
Ruthenium(II) and osmium(II) 1,2,3-triazolylidene organometallics: a preliminary investigation into the biological activity of 'click' carbene complexes.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Click Chemistry; Coordination Complexes; Crystallography, X-Ray; HEK293 Cells; Humans; Methane; Molecular Conformation; Osmium; Ruthenium; Triazoles | 2014 |
Synthesis and evaluation of new Hsp90 inhibitors based on a 1,4,5-trisubstituted 1,2,3-triazole scaffold.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Catalysis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Computational Biology; Flow Cytometry; HSP90 Heat-Shock Proteins; Humans; Indicators and Reagents; Isoxazoles; Mice; Models, Molecular; Protein Binding; Resorcinols; Ruthenium; Spectrometry, Fluorescence; Structure-Activity Relationship; Triazoles; X-Ray Diffraction; Xenograft Model Antitumor Assays | 2014 |
Bis-heteroleptic ruthenium(II) complex of a triazole ligand as a selective probe for phosphates.
Topics: Ligands; Magnetic Resonance Spectroscopy; Organometallic Compounds; Phosphates; Ruthenium; Spectrophotometry, Ultraviolet; Triazoles; X-Ray Diffraction | 2014 |
Ruthenium-catalyzed cycloadditions of 1-haloalkynes with nitrile oxides and organic azides: synthesis of 4-haloisoxazoles and 5-halotriazoles.
Topics: Alkynes; Azides; Catalysis; Cyclization; Cycloaddition Reaction; Molecular Structure; Nitriles; Oxides; Ruthenium; Triazoles | 2014 |
An organocatalytic azide-aldehyde [3+2] cycloaddition: high-yielding regioselective synthesis of 1,4-disubstituted 1,2,3-triazoles.
Topics: Aldehydes; Alkynes; Azides; Catalysis; Click Chemistry; Copper; Cycloaddition Reaction; Iridium; Ruthenium; Stereoisomerism; Triazoles | 2014 |
Are 1,4- and 1,5-disubstituted 1,2,3-triazoles good pharmacophoric groups?
Topics: Alkynes; Azides; Binding Sites; Catalysis; Click Chemistry; Copper; Cycloaddition Reaction; Databases, Protein; Protein Structure, Tertiary; Proteins; Ruthenium; Solubility; Static Electricity; Triazoles; Water | 2014 |
A ruthenium(II) complex as turn-on Cu(II) luminescent sensor based on oxidative cyclization mechanism and its application in vivo.
Topics: Animals; Aphids; Coordination Complexes; Copper; Cyclization; Luminescent Measurements; Oxidation-Reduction; Ruthenium; Triazoles | 2015 |
Ruthenium-catalyzed synthesis of 5-amino-1,2,3-triazole-4-carboxylates for triazole-based scaffolds: beyond the dimroth rearrangement.
Topics: Amino Acids; Azides; Carboxylic Acids; Catalysis; Cycloaddition Reaction; Dipeptides; HSP90 Heat-Shock Proteins; Inhibitory Concentration 50; Peptidomimetics; Ruthenium; Triazoles | 2015 |
N-type pyrazine and triazole-based luminogens with aggregation-enhanced emission characteristics.
Topics: Alkynes; Azides; Catalysis; Copper; Cycloaddition Reaction; Electrons; Pyrazines; Quantum Theory; Ruthenium; Triazoles | 2015 |
1,2,3-Triazole-based analogue of benznidazole displays remarkable activity against Trypanosoma cruzi.
Topics: Catalysis; Click Chemistry; Copper; Cycloaddition Reaction; Microwaves; Nitroimidazoles; Ruthenium; Structure-Activity Relationship; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2015 |
N- and S-donor leaving groups in triazole-based ruthena(ii)cycles: potent anticancer activity, selective activation, and mode of action studies.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Humans; Hydrogen-Ion Concentration; Ligands; Molecular Structure; Nitrogen; Ruthenium; Sulfur; Triazoles | 2018 |
Synthesis of 1-Cyanoalkynes and Their Ruthenium(II)-Catalyzed Cycloaddition with Organic Azides to Afford 4-Cyano-1,2,3-triazoles.
Topics: Alkynes; Azides; Cycloaddition Reaction; Nitriles; Ruthenium; Triazoles | 2018 |
Synthesis, structure and biological evaluation of ruthenium(III) complexes of triazolopyrimidines with anticancer properties.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Coordination Complexes; Mice; Pyrimidines; Ruthenium; Triazoles | 2020 |
Nanoencapsulation of a ruthenium(ii) complex with triazolopyrimidine in liposomes as a tool for improving its anticancer activity against melanoma cell lines.
Topics: Antineoplastic Agents; Capsules; Cell Line, Tumor; Coordination Complexes; Humans; Hydrophobic and Hydrophilic Interactions; Liposomes; Melanoma; Nanostructures; Pyrimidines; Ruthenium; Triazoles | 2020 |
Application and Structural Analysis of Triazole-Bridged Disulfide Mimetics in Cyclic Peptides.
Topics: Amino Acid Sequence; Crystallography, X-Ray; Cyclization; Disulfides; Molecular Mimicry; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Ruthenium; Triazoles | 2020 |
Formylation of a metathesis-derived
Topics: Aldehydes; Alkenes; Antineoplastic Agents; Apoptosis; Catalysis; Cell Line, Tumor; Cell Proliferation; Click Chemistry; Coordination Complexes; Drug Development; Ferrous Compounds; Humans; Isomerism; Metallocenes; Ruthenium; Structure-Activity Relationship; Triazoles | 2020 |
The aqueous dependent sensing of hydrazine and phosphate anions using a bis-heteroleptic Ru(II) complex with a phthalimide-anchored pyridine-triazole ligand.
Topics: Anions; HeLa Cells; Humans; Hydrazines; Ligands; Phosphates; Phthalimides; Pyridines; Ruthenium; Triazoles | 2021 |
Triazole-Based Half-Sandwich Ruthenium(II) Compounds: From
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Cells, Cultured; Coordination Complexes; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Membrane Potential, Mitochondrial; Models, Molecular; Molecular Conformation; Ruthenium; Triazoles | 2021 |
New Triazolyl N^N Bidentate Rh(III), Ir(III), Ru(II) and Os(II) Complexes: Synthesis and Characterization, Probing Possible Relations between Cytotoxicity with Transfer Hydrogenation Efficacy and Interaction with Model Biomolecules.
Topics: Antineoplastic Agents; Coordination Complexes; Guanosine Monophosphate; HEK293 Cells; Humans; Hydrogenation; Prostatic Hyperplasia; Pyruvic Acid; Ruthenium; Triazoles | 2022 |
Sawhorse-type ruthenium complexes with triazolopyrimidine ligands - what do they represent in terms of cytotoxic and CORM compounds?
Topics: Antineoplastic Agents; Cell Line, Tumor; Coordination Complexes; HeLa Cells; Humans; Ligands; Pyrimidines; Reactive Oxygen Species; Ruthenium; Triazoles | 2022 |
Triazolyl Ru(II), Os(II), and Ir(III) complexes as potential HIV-1 inhibitors.
Topics: Animals; Antineoplastic Agents; Coordination Complexes; HIV-1; Humans; Mammals; Models, Molecular; Ruthenium; Triazoles | 2022 |
Not All
Topics: Ligands; Organometallic Compounds; Quantum Theory; Ruthenium; Triazoles | 2022 |
Ruthenium-Catalyzed Cycloaddition for Introducing Chemical Diversity in Second-Generation β-Lactamase Inhibitors.
Topics: Alkynes; Azides; beta-Lactamase Inhibitors; Catalysis; Cycloaddition Reaction; Ruthenium; Triazoles | 2023 |